Literature DB >> 27909485

Supraventricular Tachycardia with Irregular Ventricular-Atrial Intervals and Ventriculo-Atrial Block.

Murat Sucu1, Vedat Davutoglu1, Esra Polat1.   

Abstract

The patient was a 68-year-old female with recurrent paroxysmal, regular narrow QRS complex tachycardia. We observed complete VA conduction block, during tachycardia in our patient. A characteristic feature of our patient is the noticeable irregular atrial and ventricular rates. We considered that possible mechanism of this tachycardia was atrioventricular nodal reentrant tachycardia (AVNRT) with retrograde complete type block in the upper common pathway.

Entities:  

Keywords:  AVNRT; Ablation; Upper Common Pathway

Year:  2016        PMID: 27909485      PMCID: PMC5089498          DOI: 10.4022/jafib.1385

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  4 in total

1.  Atrioventricular nodal reentrant tachycardia with ventriculoatrial block and unsuccessful ablation of the slow pathway.

Authors:  Leonardo Calò; Filippo Lamberti; Andrea Ciolli; Massimo Santini
Journal:  J Cardiovasc Electrophysiol       Date:  2002-07

Review 2.  Catheter ablation of paroxysmal supraventricular tachycardia.

Authors:  Hiroshi Nakagawa; Warren M Jackman
Journal:  Circulation       Date:  2007-11-20       Impact factor: 29.690

3.  Analysis of atrioventricular nodal reentrant tachycardia with variable ventriculoatrial block: characteristics of the upper common pathway.

Authors:  Kenji Morihisa; Hiroshige Yamabe; Takashi Uemura; Yasuaki Tanaka; Koji Enomoto; Hiroaki Kawano; Yasuhiro Nagayoshi; Koichi Kaikita; Hitoshi Sumida; Seigo Sugiyama; Hisao Ogawa
Journal:  Pacing Clin Electrophysiol       Date:  2009-04       Impact factor: 1.976

4.  Narrow complex tachycardia with irregular ventricular and atrial intervals: what is the mechanism?

Authors:  Axel Sarrias-Merce; Angel Moya-Mitjans; Nuria Rivas-Gandara; Jordi Perez-Rodon; Ivo Roca-Luque; David Garcia-Dorado
Journal:  Pacing Clin Electrophysiol       Date:  2013-03-19       Impact factor: 1.976

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.